Product Information
CLONIDINE 0.2 MG/DAY PATCH is a generic product labeled by Actavis Pharma, Inc., priced at $9.0458 per EA under NDC 00591350904. Its NADAC has been published 643 times since Jun 11, 2014.
FDA first approved this application on May 6, 2014. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
.2 mg/d
Manufacturer
Actavis Pharma, Inc.NDC
00591350904
Classification
Generic
Dosage Form
PATCH
Route
TRANSDERMAL
Effective Date
9/23/2026
Active Ingredients
CLONIDINEApproval Type
Generic (ANDA)
FDA Application
ANDA090873FDA Approved
5/6/2014
TE Code
AB
On Market Since
5/6/2014
Pharmacological Classes
Price Statistics
The NADAC for CLONIDINE 0.2 MG/DAY PATCH has been published 643 times since Jun 11, 2014, and over the history we have for it it has declined 66.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $9.0458 per EA |
|---|---|
| All-time high | $27.8946 (Aug 13, 2014) |
| All-time low | $8.8400 (Feb 18, 2026) |
| 52-week high | $10.0074 |
| 52-week low | $8.8400 |
| Median price | $13.3209 |
| Average price | $16.1592 |
| Largest weekly change | -18.3% (Nov 20, 2024) |
| Weeks tracked | 643 |
| Tracking since | Jun 11, 2014 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Clonidine market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Actavis Pharma, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Clonidine market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Central alpha-2 Adrenergic Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CLONIDINE 0.2 MG/DAY PATCH?
The current National Average Drug Acquisition Cost (NADAC) for CLONIDINE 0.2 MG/DAY PATCH, manufactured by Actavis Pharma, Inc., is $9.0458 per EA (NDC 00591350904), effective Sep 30, 2026.
How has the price of CLONIDINE 0.2 MG/DAY PATCH changed over time?
Over the history we have for it, the NADAC for CLONIDINE 0.2 MG/DAY PATCH has declined 66.8%. It has been tracked across 643 weekly CMS publications since Jun 11, 2014.
What are the highest and lowest recorded NADAC prices for CLONIDINE 0.2 MG/DAY PATCH?
Since Jun 11, 2014, the NADAC for CLONIDINE 0.2 MG/DAY PATCH has ranged from a low of $8.8400 (Feb 18, 2026) to a high of $27.8946 (Aug 13, 2014), with a median of $13.3209 per EA.
Are there cheaper alternatives to CLONIDINE 0.2 MG/DAY PATCH?
No other NADAC-published product currently shares the active ingredient and strength of CLONIDINE 0.2 MG/DAY PATCH in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures CLONIDINE 0.2 MG/DAY PATCH?
CLONIDINE 0.2 MG/DAY PATCH (NDC 00591350904) is labeled by Actavis Pharma, Inc., and CMS classifies it as a generic product.